ReviewCancers2022
MRD Monitoring by Multiparametric Flow Cytometry in AML: Is It Time to Incorporate Immune Parameters?
Ilias Pessach et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewCancers2022
Ilias Pessach et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.